New Delhi: In a first for the Indian healthcare industry, NATHEALTH, one of the country’s leading healthcare apex bodies has released its roadmap to enable healthcare access amongst people and patients, with a special focus on diagnostics and preventive medicine. Signing a Memorandum of Understanding (MoU) with Roche Diagnostics India, NATHEALTH revealed its plans to drive awareness, access and acceptance of digitalization for quality screening, diagnosis and monitoring solutions to reach people across India.
Dr. Sudarshan Ballal, President, NATHEALTH said, “The current healthcare scenario in India is unique. We have a fair balance of opportunities and challenges. To explore the full extent of the opportunities before us, there is a need for meaningful partnerships that can establish and sustain a robust healthcare ecosystem that focuses on people / patient understanding and technology in equal measure. I am pleased to announce that we have joined hands with Roche Diagnostic India to provide momentum to our efforts to push policy making that ensures greater access to medical technology and building awareness on the role advanced screening and diagnostic solutions play in reducing the disease burden of the system and the common man. We will be leveraging Roche’s diagnostics capabilities and relationships in India to achieve this objective.”
According to Dr Shravan Subramanyam, Managing Director of Roche Diagnostics India, “It is important that our approach to healthcare development in India addresses some of our immediate needs, while building a foundation of innovation that will help us keep pace with advancing age and evolving disease patterns. I believe that developments in healthcare technology helps us know the condition better and faster, while enabling reach in far flung locations. Our association with NATHEALTH is an affirmation of our focus on establishing the role up-to-date diagnostics solutions can play in enabling quality healthcare, covering medical value and economic benefit.”
Over the past six years, NATHEALTH has been focusing on bigger partnerships with public and private healthcare stakeholders, towards supporting the ‘Healthcare for all’ initiativesof the Government. Currently, the Federation is focusing on collaborations to strengthen the five critical pillars of Indian Healthcare namely Ayushman Bharat, Aarogya Bharat (Health as an economic Driver), Preventive Health, Quality & Skilling, Digital Health and Innovation & Entrepreneurship.
“We look forward to working closely with Roche Diagnostics India in building awareness on innovations in cancer diagnosis and treatments. Our combined efforts will be aimed at empowering people and patients with the knowledge of diagnostics solutions available, while enabling access to such global technologies in India,” DrBallal added.
NATHEALTH has been created with the Vision to “Be the credible and unified voice in improving access and quality of healthcare”. Leading Healthcare Service Providers, Medical Technology Providers (Devices, Equipment & IT), Diagnostic Service Providers, Health Insurance companies, Health Education Institutions, Medical Journalism companies, Biotech/Lifesciences related companies, Healthcare Publishers, Healthcare Consultants, Home Healthcare companies, PE & VC companies and other stakeholders have come together to build NATHEALTH as a common platform to create the next level of momentum in Indian Healthcare. NATHEALTH is an inclusive Institution that has representation of small & medium hospitals and nursing homes as well as Healthcare Start-up companies. NATHEALTH is committed to work on its Mission to encourage innovation, help bridge the skill and capacity gap, help shape policy & regulations and enable the environment to fund long term growth. NATHEALTH aims to help build a better and healthier future for both rural and urban India.
Roche Diagnostics India is the country’s in-vitro diagnostics market leader. The Company started its India operations in January 2002 and provides diagnostic testing solutions for early detection, evaluation and monitoring of disease. Roche Diagnostics India works with the objective of “Doing now what patients need next”, thus preparing for the future needs of healthcare in India.
On the product side, Roche Diagnostics India provides a wide range of diagnostic products for distinct areas of diabetes, virology, blood screening, women’s health, microbiology and oncology for India’s customers.
